Coagulation

Vivian Imbriotis | April 6, 2026

Don't have a thrombo, baybee.

Initiation

Vessel injury exposes bare collagen and tissue factor.

FVII \(\stackrel{\text{Tissue factor}}{\to}\) FVIIa

FX \(\stackrel{\text{FVIIa}}{\to}\) FXa

Meanwhile, platelets undergo

  • Adhesion to the denuded collagen via vWF
  • Aggregation by binding to each other via GPIIb/IIIa-fibrinogen complex
  • Activation, which releases
  1. Serotonin \(\to\) vasoconstriction
  2. Thromboxane and ADP \(\to\) activate more platelets
  3. Lots of FV

Vasoconstriction + platelet plug formation produces primary haemostasis

$$FV \xrightarrow{\text{FXa (slow)}} FV_a$$

$$\text{Prothrombin} \xrightarrow{\text{FXa+FVa+activated plt membrane+iCa}} \text{Thrombin}$$

Amplification

Thrombin...

  • Activates more platelets
  • Activates FV (from platelet granules)
  • Activates FXI, which activates FIX
  • Cleaves vWF off factor VIII and activates it; FIX+FVIII activates more FX
  • FXa + FVa + plt membrane + iCa \(\to\) more thrombin \(\to\) positive feedback


Propagation

$$\text{Fibrinogen} \xrightarrow{\text{Thrombin}} {\text{Fibrin}}$$

$$\text{FXIII} \xrightarrow{\text{Thrombin}} {XIIIa} \to \text{Crosslinks fibrin strands}$$


Negative feedback

Protein C \(\xrightarrow{\text{thrombin}}\) Protein Ca (with protein S) \(\to\) inactivates thrombin, indirectly initiates thrombolysis

Antithrombin III: circulating serine protease inhibitor that inactivates thrombin, FXa, FIXa, FXIa. Potentiated by heparin.

Intact endothelium express anticoagulants that prevent clot propogation out of area of injury

  • Tissue factor pathway inhibitor (TFPI) \(\to\) inhibits TF-VIIa complex
  • Thrombomodulin \(\to \ \uparrow\)activation of protein C by thrombin

Process

  1. Plasminogen (a plasma protein from the liver) binds to fibrin at lysine residues (N.B. TXA and aminocaproic acid resemble lysine and divert plasminogen)
  2. tPA (produced by endothelial cells) binds to plasminogen-fibrin complex
  3. tPA converts plasminogen to plasmin, which cleaves fibrin into degradation products
  4. These products...
  • Bind to GPIIb/IIIa on platelets without crosslinking \(\to\) impaired aggregation
  • Compete with fibrinogen for thrombin binding \(\to\) anticoagulation

Factors decreasing tPA activity

  • Plasminogen Activator Inhibitor 1 (PAI1): produced by endothelium and platelets, direct tPA inhibitor
  • \(\alpha\)-2 antiplasmin: binds plasmin

Factors increasing tPA activity

  • Protein C cleaves PAI1 and promotes lysis